These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30698289)

  • 1. Inhibition of microRNA-92a increases blood vessels and satellite cells in skeletal muscle but does not improve duchenne muscular dystrophy-related phenotype in mdx mice.
    Verma M; Asakura Y; Asakura A
    Muscle Nerve; 2019 May; 59(5):594-602. PubMed ID: 30698289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
    Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
    Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA miR-133b functions to slow Duchenne muscular dystrophy pathogenesis.
    Taetzsch T; Shapiro D; Eldosougi R; Myers T; Settlage RE; Valdez G
    J Physiol; 2021 Jan; 599(1):171-192. PubMed ID: 32991751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy.
    Renzini A; Marroncelli N; Cavioli G; Di Francescantonio S; Forcina L; Lambridis A; Di Giorgio E; Valente S; Mai A; Brancolini C; Giampietri C; Magenta A; De Santa F; Adamo S; Coletti D; Moresi V
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1339-1359. PubMed ID: 35170869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted expression of heme oxygenase-1 in satellite cells improves skeletal muscle pathology in dystrophic mice.
    Florczyk-Soluch U; Polak K; Jelinkova S; Bronisz-Budzyńska I; Sabo R; Bolisetty S; Agarwal A; Werner E; Józkowicz A; Stępniewski J; Szade K; Dulak J
    Skelet Muscle; 2024 Jun; 14(1):13. PubMed ID: 38867250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction.
    Alexakis C; Partridge T; Bou-Gharios G
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C661-9. PubMed ID: 17475662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice.
    Liu N; Williams AH; Maxeiner JM; Bezprozvannaya S; Shelton JM; Richardson JA; Bassel-Duby R; Olson EN
    J Clin Invest; 2012 Jun; 122(6):2054-65. PubMed ID: 22546853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation.
    Arpke RW; Darabi R; Mader TL; Zhang Y; Toyama A; Lonetree CL; Nash N; Lowe DA; Perlingeiro RC; Kyba M
    Stem Cells; 2013 Aug; 31(8):1611-20. PubMed ID: 23606600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy.
    Hayashiji N; Yuasa S; Miyagoe-Suzuki Y; Hara M; Ito N; Hashimoto H; Kusumoto D; Seki T; Tohyama S; Kodaira M; Kunitomi A; Kashimura S; Takei M; Saito Y; Okata S; Egashira T; Endo J; Sasaoka T; Takeda S; Fukuda K
    Nat Commun; 2015 Apr; 6():6745. PubMed ID: 25865621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy.
    Verma M; Shimizu-Motohashi Y; Asakura Y; Ennen JP; Bosco J; Zhou Z; Fong GH; Josiah S; Keefe D; Asakura A
    PLoS Genet; 2019 Dec; 15(12):e1008468. PubMed ID: 31877123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice.
    Gallot YS; Straughn AR; Bohnert KR; Xiong G; Hindi SM; Kumar A
    Hum Mol Genet; 2018 Oct; 27(19):3449-3463. PubMed ID: 30010933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meclozine ameliorates skeletal muscle pathology and increases muscle forces in mdx mice.
    Kawamura Y; Hida T; Ohkawara B; Matsushita M; Kobayashi T; Ishizuka S; Hiraiwa H; Tanaka S; Tsushima M; Nakashima H; Ito K; Imagama S; Ito M; Masuda A; Ishiguro N; Ohno K
    Biochem Biophys Res Commun; 2022 Feb; 592():87-92. PubMed ID: 35033871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.
    González-Sánchez J; Sánchez-Temprano A; Cid-Díaz T; Pabst-Fernández R; Mosteiro CS; Gallego R; Nogueiras R; Casabiell X; Butler-Browne GS; Mouly V; Relova JL; Pazos Y; Camiña JP
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1063-1078. PubMed ID: 30216693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
    Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
    Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice.
    Liu Y; Yan X; Sun Z; Chen B; Han Q; Li J; Zhao RC
    Stem Cells Dev; 2007 Oct; 16(5):695-706. PubMed ID: 17999592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.